The 2023 ARCS Annual Conference (6 – 8 June 2023) will be held at the International Convention Centre (ICC), Darling Harbour, Sydney.
For over 35 years, ARCS Australia has been bringing together a vibrant and diverse community of professionals working in academia, government, biotech and pharmaceutical companies, hospitals and healthcare settings and other organisations to showcase and support the development and regulation of therapeutic goods.
Delegates attend from a cross-section of the healthcare sector including clinical research, regulatory affairs, pharmacovigilance, medical affairs/MSLs, medical technology, health economics and quality/ GMP. They include senior executives through to recent graduates.
Content includes sessions on cutting-edge topics and themes along with sessions containing critical changes in the professional landscape from governments, industry leaders and independent experts.
This year, Regulink is presenting on the changes that have taken place within the MHRA since Brexit for international companies, particularly focusing on new and exciting submission pathways that aim to place the UK at the forefront of non-EU collaborative processes. This presentation will be of particular relevance to professionals involved in regulatory affairs, manufacturing and quality/GMP and the wider business executive in the Asia Pacific region.
Regulink is also hosting an educational session to expand in greater depth into MHRA procedures.
Based on last year’s conference over 1,500 delegates are expected to attend from across industry, academia and government.
If you would like to meet to discuss any of your projects or just want to connect, let us know using the contact form below.
We really look forward to meeting you there!
